Information for activists, patients, health workers & researchers working to end tuberculosis
Website of the Global Tuberculosis Community Advisory Board
By Claudio U Köser et al. Published: Jan. 23, 2015, 8:50 p.m.· Tags: Drug-resistant TB
Bedaquiline and delamanid, novel classes of anti-tuberculosis drugs, have been recently approved for the treatment of multidrug-resistant tuberculosis.
Read More →
Page 1 of 1 · Total posts: 1
